JP2020522492A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020522492A5 JP2020522492A5 JP2019566128A JP2019566128A JP2020522492A5 JP 2020522492 A5 JP2020522492 A5 JP 2020522492A5 JP 2019566128 A JP2019566128 A JP 2019566128A JP 2019566128 A JP2019566128 A JP 2019566128A JP 2020522492 A5 JP2020522492 A5 JP 2020522492A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- bont
- botulinum neurotoxin
- composition according
- including botulinum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762512792P | 2017-05-31 | 2017-05-31 | |
| US62/512,792 | 2017-05-31 | ||
| PCT/US2018/035025 WO2018222652A1 (en) | 2017-05-31 | 2018-05-30 | Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020522492A JP2020522492A (ja) | 2020-07-30 |
| JP2020522492A5 true JP2020522492A5 (https=) | 2021-07-26 |
| JP7096845B2 JP7096845B2 (ja) | 2022-07-06 |
Family
ID=62683456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019566128A Expired - Fee Related JP7096845B2 (ja) | 2017-05-31 | 2018-05-30 | メラノサイトの活動亢進および／または過剰メラニンに関連する障害の治療のためのボツリヌス神経毒素 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US10912823B2 (https=) |
| EP (1) | EP3630298A1 (https=) |
| JP (1) | JP7096845B2 (https=) |
| KR (1) | KR20200011499A (https=) |
| CN (1) | CN110891594A (https=) |
| AU (1) | AU2018277754A1 (https=) |
| BR (1) | BR112019025402A2 (https=) |
| CA (1) | CA3065542A1 (https=) |
| CL (1) | CL2019003484A1 (https=) |
| CO (1) | CO2019014592A2 (https=) |
| IL (1) | IL270986B (https=) |
| MX (1) | MX2019014349A (https=) |
| PH (1) | PH12019502721A1 (https=) |
| RU (1) | RU2019143639A (https=) |
| WO (1) | WO2018222652A1 (https=) |
| ZA (1) | ZA201907916B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102480965B1 (ko) | 2016-09-13 | 2022-12-26 | 알레간 인코포레이티드 | 안정화된 비단백질 클로스트리듐 독소 조성물 |
| BR112019025402A2 (pt) * | 2017-05-31 | 2020-06-23 | Allergan, Inc. | Neurotoxina botulínica para tratamento de distúrbios associados a hiperatividade de melanócito e/ou melanina em excesso |
| KR20210097530A (ko) * | 2020-01-30 | 2021-08-09 | (주)메디톡스 | Snare 복합체의 형성을 저해하는 펩티드, 및 그의 용도 |
| KR102550756B1 (ko) * | 2022-12-21 | 2023-07-05 | (주)메디톡스 | 세포로부터 신경전달물질 분비를 저해하는 펩티드, 및 그의 용도 |
| CN121511091A (zh) | 2023-07-12 | 2026-02-10 | 莫茨药物股份两合公司 | 通过肉毒杆菌毒素的色素沉着过度病况治疗 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6306423B1 (en) | 2000-06-02 | 2001-10-23 | Allergan Sales, Inc. | Neurotoxin implant |
| KR20050094817A (ko) * | 2002-12-20 | 2005-09-28 | 보툴리늄 톡신 리서치 어쏘시에이츠, 인크. | 개선된 약제학적 보툴리늄 독소 조성물 |
| EP1599213A4 (en) * | 2003-02-24 | 2009-07-15 | Ira Sanders | CELL MEMBRANE TRANSLOCATION OF SNARE R GUL S INHIBITORS, ASSOCIATED COMPOSITIONS AND PATHOLOGY TREATMENT PROCESSES |
| US8048423B2 (en) | 2003-12-09 | 2011-11-01 | Allergan, Inc. | Botulinum toxin therapy for skin disorders |
| US8871224B2 (en) * | 2003-12-09 | 2014-10-28 | Allergan, Inc. | Botulinum toxin therapy for skin disorders |
| US20050220734A1 (en) * | 2004-04-02 | 2005-10-06 | Allergan, Inc. | Therapy for melanin related afflictions |
| GB0820970D0 (en) * | 2008-11-17 | 2008-12-24 | Syntaxin Ltd | Suppression of cancer |
| US9744237B2 (en) * | 2009-01-29 | 2017-08-29 | Kambiz Thomas Moazed | Method and system for effecting changes in pigmented tissue |
| US20120195878A1 (en) * | 2011-01-28 | 2012-08-02 | Allergan, Inc. | Protocol for the administration of botulinum toxins |
| US20140276359A1 (en) * | 2013-03-15 | 2014-09-18 | Plum Systems Co. | Apparatus and method for tissue rejuvenation |
| AU2014301116B2 (en) * | 2013-06-28 | 2019-11-14 | Merz Pharma Gmbh & Co. Kgaa | Means and methods for the determination of the biological activity of Neurotoxin polypeptides in cells |
| CN105683212B (zh) * | 2013-08-21 | 2020-03-17 | 香港理工大学 | 高催化活性的基因改造梭菌属神经毒素 |
| WO2016048689A1 (en) * | 2014-09-23 | 2016-03-31 | Avidas Pharmaceuticals Llc | Delivery and induction of therapeutic agents and uses thereof |
| MX2019005833A (es) * | 2016-11-21 | 2019-10-30 | Eirion Therapeutics Inc | Administracion transdermica de agentes grandes. |
| BR112019025402A2 (pt) * | 2017-05-31 | 2020-06-23 | Allergan, Inc. | Neurotoxina botulínica para tratamento de distúrbios associados a hiperatividade de melanócito e/ou melanina em excesso |
| AU2018389104A1 (en) * | 2017-12-20 | 2020-07-30 | Allergan, Inc. | Botulinum toxin cell binding domain polypeptides and methods of use for skin rejuvenation |
-
2018
- 2018-05-30 BR BR112019025402-1A patent/BR112019025402A2/pt not_active Application Discontinuation
- 2018-05-30 KR KR1020197038621A patent/KR20200011499A/ko not_active Ceased
- 2018-05-30 CA CA3065542A patent/CA3065542A1/en active Pending
- 2018-05-30 JP JP2019566128A patent/JP7096845B2/ja not_active Expired - Fee Related
- 2018-05-30 EP EP18732563.4A patent/EP3630298A1/en not_active Withdrawn
- 2018-05-30 MX MX2019014349A patent/MX2019014349A/es unknown
- 2018-05-30 CN CN201880047102.5A patent/CN110891594A/zh active Pending
- 2018-05-30 AU AU2018277754A patent/AU2018277754A1/en not_active Abandoned
- 2018-05-30 WO PCT/US2018/035025 patent/WO2018222652A1/en not_active Ceased
- 2018-05-30 RU RU2019143639A patent/RU2019143639A/ru unknown
- 2018-05-30 US US15/992,627 patent/US10912823B2/en active Active
-
2019
- 2019-11-27 IL IL270986A patent/IL270986B/en unknown
- 2019-11-28 CL CL2019003484A patent/CL2019003484A1/es unknown
- 2019-11-28 ZA ZA2019/07916A patent/ZA201907916B/en unknown
- 2019-12-02 PH PH12019502721A patent/PH12019502721A1/en unknown
- 2019-12-23 CO CONC2019/0014592A patent/CO2019014592A2/es unknown
-
2021
- 2021-02-03 US US17/166,386 patent/US20210162027A1/en not_active Abandoned
-
2022
- 2022-12-21 US US18/069,535 patent/US20230302103A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020522492A5 (https=) | ||
| Levin et al. | Next generation matrix metalloproteinase inhibitors—Novel strategies bring new prospects | |
| AR069806A1 (es) | Uso de un componente neurotoxico del complejo de toxina botulinica creada por la bacteria clostridium botulinum para reducir o evitar efectos colaterales | |
| RU2019143639A (ru) | Ботулинический нейротоксин для лечения расстройств, связанных с гиперактивностью меланоцитов и/или избытком меланина | |
| AR050713A1 (es) | Uso de una neurotoxina botulinica para la preparacion de un medicamento para el tratamiento de un cancer | |
| MX377629B (es) | Composiciones farmacéuticas tópicas. | |
| BRPI0809655B8 (pt) | uso de um composto e um agente terapêutico,composição farmacêutica,e,kit | |
| MX392606B (es) | Composiciones para la liberacion controlada de cisteamina y el tratamiento sistemico de trastornos sensibles a la cisteamina. | |
| JP2015164953A5 (https=) | ||
| DE60134403D1 (de) | Behandlung des akuten koronaren syndroms mit glp-1 | |
| JP2015523973A5 (https=) | ||
| DE60121303D1 (de) | Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten | |
| DE602007002154D1 (de) | Analgesische Zusammensetzung von topisch angewendeten, nichtsteroiden und entzündungshemmenden Arzneimitteln und Opioiden | |
| JP2015521632A5 (https=) | ||
| JP2020502132A5 (https=) | ||
| BRPI0414347A (pt) | associação compreendendo um ligando de alfa-2-delta e um ssri e/ou snri para tratamento de depressão e distúrbios da ansiedade | |
| MX2022010186A (es) | Neurotoxinas botulinas para uso en terapia. | |
| Webster | Common skin disorders in the elderly | |
| AR077490A1 (es) | Composiciones farmaceuticas topicas para el tratamiento de una condicion hiperproliferativa de la piel | |
| ATE476969T1 (de) | Verwendung filmbildender haarpflegepolymere aus der gruppe der polyurethane und diese polymere enthaltende pharmazeutische zubereitungen und pflaster | |
| CO7170176A2 (es) | Nuevo compuesto que tiene la capacidad para inhibir la enzima deshidrogenasa11b-hidroxiesteroide tipo 1(11b-hsd1) o sal farmaceúticamente aceptable del mismo, método para producir el mismo, y composición farmaceútica que contiene el mismo como ingrediente activo | |
| ECSP077843A (es) | Tratamiento o prevención del prurito | |
| RU2006123436A (ru) | Применение активаторов рецепторов ppar в косметике и дерматологии | |
| Lim et al. | Botulinum toxin, quo vadis? | |
| DK2004235T3 (da) | Sammensætning til kosmetisk eller farmaceutisk-dermatologisk anvendelse |